Anebulo Pharmaceuticals I...

NASDAQ: ANEB · Real-Time Price · USD
2.53
-0.05 (-1.90%)
At close: Aug 19, 2025, 11:45 AM

Anebulo Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
PE Ratio
-8.44 -5.02 -17.78 -5.26
PEG Ratio
0.26 -0.08 0.23 -0.00
PS Ratio
n/a n/a n/a n/a
PB Ratio
18.15 5.56 8.06 7.44
P/FCF Ratio
-8.55 -6.09 -22.33 -32.68
P/OCF Ratio
-8.55 -6.09 -22.33 -32.68
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
n/a n/a n/a n/a
Quick Ratio
13.46 21.04 28.39 82.71
Current Ratio
13.46 21.04 28.39 82.71
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-54.94 n/a -931.67 -307.13
Return on Equity
-2.15 -1.11 -0.45 -1.41
Return on Assets
-2.01 -1.01 -0.44 -1.4
Return on Invested Capital
-2.18 -1.09 -0.45 -0.17
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a